DOI:
10.1055/s-00000036
Laryngo-Rhino-Otologie
LinksClose Window
References
Kaufman HL, Andtbacka RHI, Collichio FA. et al.
Durable response rate as an endpoint in cancer immunotherapy: insights from oncolytic virus clinical trials.
Journal for immunotherapy of cancer 2017;
5: 72
We do not assume any responsibility for the contents of the web pages of other providers.